Filing Flows › Embecta (EMBC) › Recalls, complaints & regulation
Embecta (EMBC): recalls
Embecta (EMBC) beyond its filings: 2 recalls in the last 12 months (3 in five years, 0 Class I).
Latest recalls
- 2026-09-23 · FDA device · EWO_02512 (Catalog number 320550) For Investigational Use Only Nano Pro Un-Cannulated Demo Samples Quantity 100
- 2026-09-23 · FDA device · EWO_02513 (Catalog number 320122) For Investigational Use Only Nano Un-Cannulated Demo Samples Quantity 100
- 2024-07-31 · FDA device · BD Nano 2nd Gen Pen Needles 32G X 4mm (5-count sample contained in Patient Counseling Sample Toolbox -Catalog 6484755/Lot Number: 3750144)-Sterile, single use d
Embecta's latest quarter
Embecta, Q3 FY26: revenue $272M (-8% year over year), operating margin 17.9%, net earnings $21.1M, operating cash flow $41.8M. The chart follows the revenue to costs, profit and cash.
Questions
Has Embecta had any recalls?
3 recalls on file over five years from the FDA, CPSC and NHTSA; 2 in the last 12 months.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.